Medroxyprogesterone acetate and prednisone in advanced breast cancer. A randomized trial
- 1 September 1986
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (9) , 1067-1072
- https://doi.org/10.1016/0277-5379(86)90007-6
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer.Journal of Clinical Oncology, 1984
- Oral high-dose medroxyprogesterone acetate causes adrenal suppression in patients with breast cancerEuropean Journal of Cancer and Clinical Oncology, 1982
- Medroxyprogesterone Acetate (MPA) Plasma Levels After Oral and Intramuscular Administration in A Long‐Term StudyActa Obstetricia et Gynecologica Scandinavica, 1981
- High-dose medroxyprogesterone acetate in breast cancer resistant to endocrine and cytotoxic therapyCancer Chemotherapy and Pharmacology, 1979
- Assessment of response to therapy in advanced breast cancerPublished by Elsevier ,1977